Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down double digits in premarket trading. CagriSema, a drug that Novo Nordisk had hoped would become its next generation weight-loss aid, has failed to meet expectations in late-stage trials, sending shares of the pharmaceutical giant tumbling as much as 24% at one point in premarket trading on Friday morning. 

BING NEWS:
  • Novo Nordisk stock just tanked 25%: here’s what happened
    Novo Nordisk stock ... next-generation treatment for obesity. CagriSema is a two-drug injectable that combines Cagrilintide and Semaglutide. Cagrilintide is a novel approach for weight loss but ...
    12/20/2024 - 4:26 am | View Link
  • Novo Nordisk shares plummet after weight-loss drug’s disappointing trial results
    Investors and analysts had eagerly awaited this data as a test of Novo’s case that it has a strong pipeline of drugs to follow Wegovy in the fiercely competitive anti-obesity market.
    12/20/2024 - 3:00 am | View Link
  • Novo Nordisk Stock Crashes More Than 20% After Disappointing Obesity Drug Data. Eli Lilly Shares Soar.
    Novo Nordisk stock fell sharply early Friday after the pharmaceutical giant, known for its blockbuster drugs Ozempic and Wegovy, posted disappointing clinical trial data for its experimental obesity ...
    12/20/2024 - 1:20 am | View Link
  • Novo Nordisk Sinks on Disappointing Trial Results for Next Gen Weight Loss Drug
    Novo Nordisk's U.S.-listed shares sank over 19% in premarket trading Friday after releasing trial results for its next generation of weight loss drug, meant to add to its current lineup of Ozempic and ...
    12/20/2024 - 12:03 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News